In his role as Head of Sanofi U.S. and Sanofi Genzyme Corporate Affairs, Adam Gluck leads the Sanofi U.S. and Sanofi Genzyme Corporate Affairs teams and aligns the activities of our Communications & CSR, Public Affairs & Patient Advocacy, Government Affairs, and Reimbursement & Policy teams to drive value for Sanofi and the patients we serve.
He has more than 25 years of experience in the policy, advocacy and healthcare industry and spent his career primarily in Washington, D.C., as well as Europe and Asia, working alongside public servants advocating for people and ensuring they have access to the best healthcare opportunities. He brings this patient-first perspective to his current role where he ensures that Sanofi’s innovation reaches the people who need it the most.
Adam joined Sanofi from Biogen, where he was most recently the Vice President of U.S. Government Affairs & Patient Advocacy. In this role, Adam led the U.S. federal, state, policy, and patient advocacy teams. During his nine years at Biogen, Adam served as the company’s lead federal lobbyist and was responsible for designing and building their European Public Policy & Government Affairs organization.
Prior to joining Biogen, Adam was a Senior Managing Director at Sonnenschein Nath & Rosenthal LLP (now Dentons LLP), where he led the Public Law and Policy Strategies public health practice team. At Sonnenschein, Adam represented a diverse range of patient advocacy organizations and corporations before the U.S. Congress and Executive branch. His career also includes close to 10 years on Capitol Hill working for four Congressional Members, including working as senior health policy advisor to Senator Tom Harkin (D-IA) and legislative director for Congressman Gene Green (D-TX). Adam was also the Senior House Legislative Liaison for the Children’s Defense Fund.
Adam holds a Bachelor of Arts degree in Political Science from the University of Michigan.